Novel CALR somatic mutations in essential thrombocythaemia

Br J Haematol. 2016 Jun;173(5):797-801. doi: 10.1111/bjh.13638. Epub 2015 Sep 7.

Ludovica Riera^{1

2}, Simona Osella-Abate^{3

4}, Giulia Benevolo⁵, Eloise Beggiato⁶, Simone Ferrero⁷, Achille Pich^{3

8}, Paola Francia di Celle³

¹ Section of Pathology, AO Città della Salute e della Scienza, Torino, Italy. ludovica.riera@unito.it.
² Section of Pathology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy. ludovica.riera@unito.it.
³ Section of Pathology, AO Città della Salute e della Scienza, Torino, Italy.
⁴ Department of Medical Sciences, Section of Dermatology, University of Torino, Torino, Italy.
⁵ SC Haematology, AO Città della Salute e della Scienza, Torino, Italy.
⁶ University Division of Haematology and Cell Therapy, Mauriziano Hospital, Torino, Italy.
⁷ Division of Haematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
⁸ Section of Pathology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.

No abstract available

Keywords: JAK2; calreticulin; essential thrombocythaemia; mutations; myeloproliferative.

Publication types